In vitro investigation of the antimicrobial activities of novel tetramethylpiperidine-substituted phenazines against Mycobacterium tuberculosis

Chemotherapy

Volumn 46, Issue 1, 2000, Pages 43-48

  Van Rensburg, Constance E J ^a,d   Jooné, Gisela K ^a   Sirgel, Frederick A ^b   Matlola, Nthane M ^a   O'Sullivan, John F ^c  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c University College Belfield   (Ireland)

^d UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Macrophages; Mycobacterium tuberculosis; Tetramethylpiperidine substituted phenazines

Indexed keywords

CLOFAZIMINE; PHENAZINE DERIVATIVE; PIPERIDINE DERIVATIVE; RIFAMPICIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; HUMAN; HUMAN CELL; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0033987119     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007255     Document Type: Article

References (19)

1. Barry VC, Belton JG, Conalty ML, Denneny JM, Edward DW, O'Sullivan JF, Twomey D, Winder F: A new series of phenazines (rimino-compounds) with high antituberculosis activity. Nature 1957;179: 1013-1015.
2. Browne SG: Treatment of leprosy with B663. Appraisal of the pilot trial after three years. Lepr Rev 1965;36:13-15.
3. Atkinson AJ, Shaegren JN, Rubio JB, Knight V: Evaluation of B663 in human leprosy. Int J Lepr 1967;35: 119-127.
4. World Health Organization: Chemotherapy of leprosy for control programmes. Report of a WHO study group. World Health Organ Tech Rep Ser 1982;675:7-33.
5. Wandorff-Van Diepen T: Clofazimine resistant leprosy - a case report. Int J Lepr 1982;50:123-127.
6. Young LS: Mycobacterium avium complex infections. J Infect Dis 1988;157:863-867.
7. Agins BD, Berman DS, Spicehandler D, El-Sadr W, Simberkoff MS, Rahal JJ: Effect of combined therapy with ansamycin, clofazimine, ethambutol and isoniazid for Mycobacterium avium infection in patients with AIDS. J Infect Dis 1989; 159:784-786.
8. Dautzenberg B, Truffot C, Mignon A, Rozenbaum W, Katlama C, Perronne C, Parrot R, Grosset J: Rifabutin in combination with clofazimine, isoniazid and ethambutol in the treatment of AIDS patients with infections due to opportunistic mycobacteria. Tubercle 1991;72:168-175.
9. Barry VC, Conalty ML: The antimycobacterial activity of B663. Lepr Rev 1965;36:3-7.
10. Donaldson R, Wallace A: Drug-resistant pulmonary tuberculosis treated with ethambutol, a rifamycin and a riminophenazine (B663). Br J Dis Chest 1970;64:161-163.
11. Franzblau SG, White KE, O'Sullivan JF: Structure-activity relationships of tetramethylpiperidine-substituted phenazines against Mycobacterium leprae in vitro. Antimicrob Agents Chemother 1989;33: 2004-2005.
12. Geeta N, Reddy MV, Jagannath C, O'Sullivan JF, Gangadharam PRJ: Activity of riminophenazine compounds against susceptible and drug resistant M. tuberculosis (abstract 89). Tuber Lung Dis 1994;75:25-26.
13. Lee C, Hiefets L: Determination of minimal inhibitory concentrations of anti-tuberculous drugs by radiometric and conventional methods. Am Rev Respir Dis 1987;136:349-352.
14. Van Rensburg CEJ, Jooné GK, Anderson R: An in vitro investigation of the hioactivitics of ciprofloxacin and the new fluoroquinolone agents clinafloxacin (CI-960) and PD131628 against Mycobacterium tuberculosis in human macrophages. Chemotherapy 1995;41:234-238.
15. O'Connor R, O'Sullivan JF, O'Kennedy R: A preliminary investigation of selected antimycobacterial phenazines. Int J Lepr, in press.
16. O'Sullivan JF, Franzblau SG, White KE: New clofazimine analogues: A structure activity study in vitro. Health Coop Pap 1992;12:191-197.
17. Crowle JC, Elkins N, May MH: Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampicin against M. tuberculosis in cultured human macrophages. Am Rev Respir Dis 1988;137:1141-1146.
18. Jagannath C, Reddy MV, Kailasam S, O'Sullivan JF, Gangadharam PRJ: Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis. In vitro, intracellular, and in vivo studies. Am J Respir Crit Care Med 1995;151:1083-1086.
19. Reddy VM, Nadadhur G, Daneluzzi D, O'Sullivan JF, Gangadharam PRJ: Antituberculosis activities of clofazimine and its new analogues B4154 and B4157. Antimicrob Agents Chemother 1996;40:633-636.